BB
Biotech AG Bb
10% Owner

Biotech AG Bb insider trades: Black Diamond Therapeutics (BDTX) stock buys and sales

10% Owner, Black Diamond Therapeutics Last trade Mar 19, 2025 138 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
131
Open-market trades
since 2014
8
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Biotech reports to the SEC

and 2 more companies

Open-market buys and sales

131 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 19, 2025BDTX↓ Sell$12.0M
Nov 14, 2024MTEM↓ Sell$846K
Nov 1, 2024EPIX↓ Sell$12.0M
Apr 2, 2024MTEM↑ Buy$588K
Oct 17, 2023BDTX↑ Buy$934K
Oct 2, 2023MGNX↑ Buy$670K
Sep 7, 2023MGNX↑ Buy$1.1M
Jul 17, 2023MTEM↑ Buy$2.0M
Jun 30, 2023BDTX↑ Buy$5.0M
Jun 27, 2023BDTX↑ Buy$9.6M
Feb 14, 2023MGNX↑ Buy$2.5M
Jan 19, 2023MGNX↑ Buy$795K
Dec 27, 2022MGNX↑ Buy$2.3M
Nov 22, 2022MGNX↑ Buy$1.8M
Oct 31, 2022BDTX↑ Buy$225K
Oct 28, 2022BDTX↑ Buy$736K
Oct 27, 2022EPIX↑ Buy$8.2M
Oct 24, 2022MGNX↑ Buy$2.2M
Oct 21, 2022BDTX↑ Buy$133K
Oct 20, 2022MGNX↑ Buy$1.8M
Oct 20, 2022BDTX↑ Buy$179K
Jul 18, 2022EPIX↑ Buy$947K
Jul 15, 2022EPIX↑ Buy$1.7M
May 18, 2022RDUS↑ Buy$2.7M
May 16, 2022MTEM↑ Buy$236K
Apr 28, 2022BDTX↑ Buy$1.1M
Apr 27, 2022EPIX↓ Sell$147K
Apr 19, 2022BDTX↑ Buy$981K
Apr 13, 2022BDTX↑ Buy$880K
Jan 6, 2022MTEM↑ Buy$807K
Jan 6, 2022RDUS↑ Buy$3.5M
Nov 19, 2021MGNX↑ Buy$3.7M
Sep 29, 2021RDUS↑ Buy$1.3M
Sep 29, 2021MGNX↑ Buy$4.1M
Sep 22, 2021RDUS↑ Buy$1.8M
Sep 21, 2021MTEM↑ Buy$4.5M
Sep 17, 2021MGNX↑ Buy$12.4M
Sep 16, 2021MTEM↑ Buy$613K
Aug 18, 2021EPIX↑ Buy$2.2M
Jul 27, 2021MTEM↑ Buy$1.1M
Jul 20, 2021MTEM↑ Buy$1.7M
Jun 21, 2021MGNX↑ Buy$1.6M
Jun 16, 2021MGNX↑ Buy$3.6M
May 24, 2021ESPR↑ Buy$2.0M
May 19, 2021ESPR↑ Buy$4.1M
May 6, 2021ESPR↑ Buy$4.6M
Apr 19, 2021MTEM↑ Buy$330K
Apr 15, 2021MTEM↑ Buy$1.3M
Apr 14, 2021MTEM↑ Buy$2.0M
Apr 12, 2021MTEM↑ Buy$2.3M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Biotech AG Bb's insider trades

Biotech AG Bb is a 10% owner of Black Diamond Therapeutics (BDTX). Since Jun 6, 2014, Biotech has reported 127 open-market purchases worth $318.5M and 4 sales worth $25.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include other transactions (8 filings), option exercises (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BDTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.